CI_with has_Ingredient has_MoA has_PE may_prevent may_treat drug associated with AE in adult drug associated with AE in pediatric used to treat disease Lipoxygenase Inhibitors [MoA] Glucocorticoid Receptor Agonists [MoA] Adrenal Insufficiency [Disease/Finding] Asthma [Disease/Finding] Bronchial Spasm [Disease/Finding] Drug Hypersensitivity [Disease/Finding] Facial Dermatoses [Disease/Finding] Foot Dermatoses [Disease/Finding] Hand Dermatoses [Disease/Finding] Infection [Disease/Finding] Inflammation [Disease/Finding] Leg Dermatoses [Disease/Finding] Lupus Erythematosus, Systemic [Disease/Finding] Mycoses [Disease/Finding] Rheumatic Diseases [Disease/Finding] Rhinitis, Allergic, Perennial [Disease/Finding] Scalp Dermatoses [Disease/Finding] Status Asthmaticus [Disease/Finding] Triamcinolone [Chemical/Ingredient] Carbohydrate Metabolism Alteration [PE] Decreased Cytokine Activity [PE] Decreased Glucocorticoid Secretion [PE] Decreased Leukotriene Activity [PE] Decreased Prostaglandin Activity [PE] Decreased Protein Synthesis [PE] Decreased Thromboxane Activity [PE] Lipid Metabolism Alteration [PE] Lysosomal Function Alteration [PE] Decreased Polymorphonuclear Leukocyte Migration [PE] Decreased Fibroblast Migration [PE] Decreased Capillary Permeability [PE] T [Preparations] TRIAMCINOLONE http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/012802s031lbl.pdf C21066 1ZK20VI6TY Active 10759 N0000145980 <VANDF_Record>50.6^93^</VANDF_Record><VA_File>50.6</VA_File><VA_IEN>93</VA_IEN> <VANDF_Record>50.416^192^</VANDF_Record><VA_File>50.416</VA_File><VA_IEN>192</VA_IEN> Triamcinolone 4017599 C0040864 TRIAMCINOLONE Ingredient allergic hypersensitivity disease dermatitis AE acne AE pruritus AE anaphylactoid reaction AE angioedema AE skin striae AE edema AE hypersensitivity AE erythema AE burning sensation AE dry skin AE folliculitis AE irritation AE anaphylaxis AE skin atrophy AE skin hypopigmentation AE hypertrichosis AE